25 XP   0   0   10

UCB SA ADR
Buy, Hold or Sell?

Let's analyse Ucb together

PenkeI guess you are interested in UCB SA ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of UCB SA ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about UCB SA ADR

I send you an email if I find something interesting about UCB SA ADR.

Quick analysis of Ucb (30 sec.)










What can you expect buying and holding a share of Ucb? (30 sec.)

How much money do you get?

How much money do you get?
$2.87
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$23.65
Expected worth in 1 year
$25.19
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$4.41
Return On Investment
7.2%

For what price can you sell your share?

Current Price per Share
$61.62
Expected price per share
$56.77 - $
How sure are you?
50%

1. Valuation of Ucb (5 min.)




Live pricePrice per Share (EOD)

$61.62

Intrinsic Value Per Share

$2.51 - $24.29

Total Value Per Share

$26.16 - $47.94

2. Growth of Ucb (5 min.)




Is Ucb growing?

Current yearPrevious yearGrowGrow %
How rich?$8.9b$9b-$89m-1.0%

How much money is Ucb making?

Current yearPrevious yearGrowGrow %
Making money$371m$452.1m-$81.1m-21.9%
Net Profit Margin6.5%7.6%--

How much money comes from the company's main activities?

3. Financial Health of Ucb (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#9 / 1031

Most Revenue
#3 / 1031

Most Profit
#9 / 1031

Most Efficient
#143 / 1031

What can you expect buying and holding a share of Ucb? (5 min.)

Welcome investor! Ucb's management wants to use your money to grow the business. In return you get a share of Ucb.

What can you expect buying and holding a share of Ucb?

First you should know what it really means to hold a share of Ucb. And how you can make/lose money.

Speculation

The Price per Share of Ucb is $61.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ucb.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ucb, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $23.65. Based on the TTM, the Book Value Change Per Share is $0.39 per quarter. Based on the YOY, the Book Value Change Per Share is $1.67 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.72 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ucb.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.981.6%0.981.6%1.161.9%1.883.0%1.772.9%
Usd Book Value Change Per Share0.390.6%0.390.6%1.672.7%1.432.3%1.151.9%
Usd Dividend Per Share0.721.2%0.721.2%0.691.1%0.681.1%0.661.1%
Usd Total Gains Per Share1.101.8%1.101.8%2.353.8%2.113.4%1.812.9%
Usd Price Per Share43.60-43.60-39.25-46.39-42.80-
Price to Earnings Ratio44.60-44.60-33.83-28.20-28.87-
Price-to-Total Gains Ratio39.51-39.51-16.68-28.92-31.13-
Price to Book Ratio1.84-1.84-1.69-2.22-2.45-
Price-to-Total Gains Ratio39.51-39.51-16.68-28.92-31.13-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share61.615
Number of shares16
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.720.68
Usd Book Value Change Per Share0.391.43
Usd Total Gains Per Share1.102.11
Gains per Quarter (16 shares)17.6633.74
Gains per Year (16 shares)70.63134.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
14625614392125
2924913286183260
313874203130275395
418499274173367530
5230123345216459665
6276148416259550800
7322173487303642935
83681975583467341070
94142226293898261205
104602477004329171340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%18.04.00.081.8%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.03.086.4%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.03.00.086.4%

Fundamentals of Ucb

About UCB SA ADR

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies. It also offers Evenity for the treatment of osteoporosis in postmenopausal women; Bimzelx for treating plaque psoriasis, psoriatic arthritis, and axial spondyloarthritis; and Fintepla to treat Dravet syndrome. In addition, the company is involved in developing rozanolixizumab and Zilbrisq to treat myasthenia gravis; dapirolizumab pegol for systemic lupus erythematosus; fenfluramine to treat CDKL5 deficiency disorder; doxecitine for TK2 deficiency disorder; STACCATO alprazolam for stereotypical prolonged seizures; bepranemab to treat Alzheimer's disease; minzasolmin and UCB0222 for Parkinson's disease; and UCB1381 and UCB9741 for atropic dermatitis. Further, it engages in contract manufacturing activities. UCB SA has collaboration agreements with Amgen, Biogen, Roche/Genentech, Novartis, and Otsuka. The company was incorporated in 1925 and is headquartered in Brussels, Belgium.

Fundamental data was last updated by Penke on 2024-03-13 13:19:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of UCB SA ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ucb earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Net Profit Margin of 6.5% means that $0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of UCB SA ADR:

  • The MRQ is 6.5%. The company is making a profit. +1
  • The TTM is 6.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.5%TTM6.5%0.0%
TTM6.5%YOY7.6%-1.0%
TTM6.5%5Y12.4%-5.9%
5Y12.4%10Y13.1%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.5%-159.2%+165.7%
TTM6.5%-202.3%+208.8%
YOY7.6%-263.0%+270.6%
5Y12.4%-452.4%+464.8%
10Y13.1%-589.0%+602.1%
1.1.2. Return on Assets

Shows how efficient Ucb is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • 2.4% Return on Assets means that Ucb generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of UCB SA ADR:

  • The MRQ is 2.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.4%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.4%TTM2.4%0.0%
TTM2.4%YOY2.8%-0.5%
TTM2.4%5Y5.4%-3.0%
5Y5.4%10Y5.7%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4%-12.5%+14.9%
TTM2.4%-12.2%+14.6%
YOY2.8%-11.2%+14.0%
5Y5.4%-13.3%+18.7%
10Y5.7%-14.6%+20.3%
1.1.3. Return on Equity

Shows how efficient Ucb is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • 4.1% Return on Equity means Ucb generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of UCB SA ADR:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY5.0%-0.9%
TTM4.1%5Y9.2%-5.0%
5Y9.2%10Y10.0%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%-16.0%+20.1%
TTM4.1%-15.8%+19.9%
YOY5.0%-13.9%+18.9%
5Y9.2%-18.2%+27.4%
10Y10.0%-19.1%+29.1%

1.2. Operating Efficiency of UCB SA ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ucb is operating .

  • Measures how much profit Ucb makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • An Operating Margin of 11.1% means the company generated $0.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of UCB SA ADR:

  • The MRQ is 11.1%. The company is operating less efficient.
  • The TTM is 11.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ11.1%TTM11.1%0.0%
TTM11.1%YOY10.6%+0.5%
TTM11.1%5Y16.8%-5.7%
5Y16.8%10Y18.1%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.1%-299.5%+310.6%
TTM11.1%-208.5%+219.6%
YOY10.6%-280.2%+290.8%
5Y16.8%-459.9%+476.7%
10Y18.1%-596.9%+615.0%
1.2.2. Operating Ratio

Measures how efficient Ucb is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.88 means that the operating costs are $0.88 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of UCB SA ADR:

  • The MRQ is 0.882. The company is less efficient in keeping operating costs low.
  • The TTM is 0.882. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.882TTM0.8820.000
TTM0.882YOY0.873+0.009
TTM0.8825Y0.820+0.061
5Y0.82010Y0.806+0.014
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8822.817-1.935
TTM0.8823.181-2.299
YOY0.8733.609-2.736
5Y0.8205.554-4.734
10Y0.8067.396-6.590

1.3. Liquidity of UCB SA ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ucb is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.32 means the company has $1.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of UCB SA ADR:

  • The MRQ is 1.317. The company is just able to pay all its short-term debts.
  • The TTM is 1.317. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.317TTM1.3170.000
TTM1.317YOY1.062+0.255
TTM1.3175Y1.268+0.048
5Y1.26810Y1.199+0.069
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3173.987-2.670
TTM1.3174.440-3.123
YOY1.0625.569-4.507
5Y1.2686.158-4.890
10Y1.1996.492-5.293
1.3.2. Quick Ratio

Measures if Ucb is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Quick Ratio of 0.91 means the company can pay off $0.91 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of UCB SA ADR:

  • The MRQ is 0.914. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.914. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.914TTM0.9140.000
TTM0.914YOY0.849+0.065
TTM0.9145Y0.945-0.031
5Y0.94510Y0.862+0.082
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9143.653-2.739
TTM0.9144.158-3.244
YOY0.8495.515-4.666
5Y0.9456.012-5.067
10Y0.8626.206-5.344

1.4. Solvency of UCB SA ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ucb assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ucb to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.42 means that Ucb assets are financed with 42.2% credit (debt) and the remaining percentage (100% - 42.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of UCB SA ADR:

  • The MRQ is 0.422. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.422. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.422TTM0.4220.000
TTM0.422YOY0.429-0.006
TTM0.4225Y0.417+0.006
5Y0.41710Y0.439-0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4220.336+0.086
TTM0.4220.330+0.092
YOY0.4290.267+0.162
5Y0.4170.367+0.050
10Y0.4390.378+0.061
1.4.2. Debt to Equity Ratio

Measures if Ucb is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ucb to the Biotechnology industry mean.
  • A Debt to Equity ratio of 73.1% means that company has $0.73 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of UCB SA ADR:

  • The MRQ is 0.731. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.731. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.731TTM0.7310.000
TTM0.731YOY0.751-0.019
TTM0.7315Y0.717+0.014
5Y0.71710Y0.784-0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7310.376+0.355
TTM0.7310.398+0.333
YOY0.7510.334+0.417
5Y0.7170.431+0.286
10Y0.7840.476+0.308

2. Market Valuation of UCB SA ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ucb generates.

  • Above 15 is considered overpriced but always compare Ucb to the Biotechnology industry mean.
  • A PE ratio of 44.60 means the investor is paying $44.60 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of UCB SA ADR:

  • The EOD is 63.032. Based on the earnings, the company is expensive. -2
  • The MRQ is 44.602. Based on the earnings, the company is overpriced. -1
  • The TTM is 44.602. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD63.032MRQ44.602+18.429
MRQ44.602TTM44.6020.000
TTM44.602YOY33.829+10.774
TTM44.6025Y28.204+16.398
5Y28.20410Y28.874-0.670
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD63.032-2.697+65.729
MRQ44.602-2.422+47.024
TTM44.602-2.709+47.311
YOY33.829-4.116+37.945
5Y28.204-6.257+34.461
10Y28.874-6.478+35.352
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of UCB SA ADR:

  • The EOD is 48.584. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 34.379. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 34.379. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD48.584MRQ34.379+14.205
MRQ34.379TTM34.3790.000
TTM34.379YOY18.904+15.475
TTM34.3795Y24.407+9.972
5Y24.40710Y39.642-15.235
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD48.584-3.344+51.928
MRQ34.379-2.939+37.318
TTM34.379-3.486+37.865
YOY18.904-5.592+24.496
5Y24.407-8.464+32.871
10Y39.642-8.872+48.514
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ucb is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.84 means the investor is paying $1.84 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of UCB SA ADR:

  • The EOD is 2.606. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.844. Based on the equity, the company is underpriced. +1
  • The TTM is 1.844. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.606MRQ1.844+0.762
MRQ1.844TTM1.8440.000
TTM1.844YOY1.688+0.156
TTM1.8445Y2.224-0.380
5Y2.22410Y2.454-0.230
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6062.198+0.408
MRQ1.8442.042-0.198
TTM1.8442.121-0.277
YOY1.6882.907-1.219
5Y2.2243.682-1.458
10Y2.4544.114-1.660
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of UCB SA ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3850.3850%1.667-77%1.433-73%1.152-67%
Book Value Per Share--23.64623.6460%23.261+2%21.137+12%17.908+32%
Current Ratio--1.3171.3170%1.062+24%1.268+4%1.199+10%
Debt To Asset Ratio--0.4220.4220%0.429-1%0.417+1%0.439-4%
Debt To Equity Ratio--0.7310.7310%0.751-3%0.717+2%0.784-7%
Dividend Per Share--0.7180.7180%0.686+5%0.675+6%0.656+9%
Eps--0.9780.9780%1.160-16%1.876-48%1.766-45%
Free Cash Flow Per Share--1.2681.2680%2.076-39%2.002-37%1.630-22%
Free Cash Flow To Equity Per Share--0.3900.3900%2.271-83%1.553-75%0.502-22%
Gross Profit Margin---3.647-3.6470%-2.562-30%-1.510-59%-1.199-67%
Intrinsic Value_10Y_max--24.295--------
Intrinsic Value_10Y_min--2.509--------
Intrinsic Value_1Y_max--2.176--------
Intrinsic Value_1Y_min--1.295--------
Intrinsic Value_3Y_max--6.736--------
Intrinsic Value_3Y_min--3.011--------
Intrinsic Value_5Y_max--11.532--------
Intrinsic Value_5Y_min--3.748--------
Market Cap23386157602.080+29%16548510451.20016548510451.2000%15295638004.000+8%17877939856.909-7%16380258157.811+1%
Net Profit Margin--0.0650.0650%0.076-14%0.124-48%0.131-50%
Operating Margin--0.1110.1110%0.106+5%0.168-34%0.181-39%
Operating Ratio--0.8820.8820%0.873+1%0.820+7%0.806+9%
Pb Ratio2.606+29%1.8441.8440%1.688+9%2.224-17%2.454-25%
Pe Ratio63.032+29%44.60244.6020%33.829+32%28.204+58%28.874+54%
Price Per Share61.615+29%43.60043.6000%39.253+11%46.385-6%42.798+2%
Price To Free Cash Flow Ratio48.584+29%34.37934.3790%18.904+82%24.407+41%39.642-13%
Price To Total Gains Ratio55.831+29%39.50739.5070%16.684+137%28.921+37%31.127+27%
Quick Ratio--0.9140.9140%0.849+8%0.945-3%0.862+6%
Return On Assets--0.0240.0240%0.028-16%0.054-56%0.057-58%
Return On Equity--0.0410.0410%0.050-17%0.092-55%0.100-59%
Total Gains Per Share--1.1041.1040%2.353-53%2.109-48%1.808-39%
Usd Book Value--8975000000.0008975000000.0000%9064000000.000-1%8141200000.000+10%6856200000.000+31%
Usd Book Value Change Per Share--0.3850.3850%1.667-77%1.433-73%1.152-67%
Usd Book Value Per Share--23.64623.6460%23.261+2%21.137+12%17.908+32%
Usd Dividend Per Share--0.7180.7180%0.686+5%0.675+6%0.656+9%
Usd Eps--0.9780.9780%1.160-16%1.876-48%1.766-45%
Usd Free Cash Flow--481356500.000481356500.0000%809111600.000-41%772982820.000-38%625114430.000-23%
Usd Free Cash Flow Per Share--1.2681.2680%2.076-39%2.002-37%1.630-22%
Usd Free Cash Flow To Equity Per Share--0.3900.3900%2.271-83%1.553-75%0.502-22%
Usd Market Cap23386157602.080+29%16548510451.20016548510451.2000%15295638004.000+8%17877939856.909-7%16380258157.811+1%
Usd Price Per Share61.615+29%43.60043.6000%39.253+11%46.385-6%42.798+2%
Usd Profit--371023100.000371023100.0000%452150600.000-18%723224620.000-49%675846160.000-45%
Usd Revenue--5681088400.0005681088400.0000%5967738900.000-5%5799210040.000-2%5123580220.000+11%
Usd Total Gains Per Share--1.1041.1040%2.353-53%2.109-48%1.808-39%
 EOD+4 -4MRQTTM+0 -0YOY+13 -235Y+9 -2710Y+16 -20

3.2. Fundamental Score

Let's check the fundamental score of UCB SA ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1563.032
Price to Book Ratio (EOD)Between0-12.606
Net Profit Margin (MRQ)Greater than00.065
Operating Margin (MRQ)Greater than00.111
Quick Ratio (MRQ)Greater than10.914
Current Ratio (MRQ)Greater than11.317
Debt to Asset Ratio (MRQ)Less than10.422
Debt to Equity Ratio (MRQ)Less than10.731
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.024
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of UCB SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.619
Ma 20Greater thanMa 5059.619
Ma 50Greater thanMa 10053.346
Ma 100Greater thanMa 20046.872
OpenGreater thanClose61.262
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Short Long Term Debt  268,000128,000396,000-379,00017,000205,000222,000-223,000-1,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets15,539,000
Total Liabilities6,564,000
Total Stockholder Equity8,975,000
 As reported
Total Liabilities 6,564,000
Total Stockholder Equity+ 8,975,000
Total Assets = 15,539,000

Assets

Total Assets15,539,000
Total Current Assets3,444,000
Long-term Assets12,095,000
Total Current Assets
Cash And Cash Equivalents 861,000
Short-term Investments 195,000
Net Receivables 1,140,000
Inventory 1,031,000
Other Current Assets 304,000
Total Current Assets  (as reported)3,444,000
Total Current Assets  (calculated)3,531,000
+/- 87,000
Long-term Assets
Property Plant Equipment 1,595,000
Goodwill 5,254,000
Intangible Assets 4,232,000
Long-term Assets Other 267,000
Long-term Assets  (as reported)12,095,000
Long-term Assets  (calculated)11,348,000
+/- 747,000

Liabilities & Shareholders' Equity

Total Current Liabilities2,616,000
Long-term Liabilities3,948,000
Total Stockholder Equity8,975,000
Total Current Liabilities
Short-term Debt 42,000
Short Long Term Debt -1,000
Accounts payable 537,000
Other Current Liabilities 1,833,000
Total Current Liabilities  (as reported)2,616,000
Total Current Liabilities  (calculated)2,411,000
+/- 205,000
Long-term Liabilities
Long term Debt 2,878,000
Capital Lease Obligations 161,000
Long-term Liabilities  (as reported)3,948,000
Long-term Liabilities  (calculated)3,039,000
+/- 909,000
Total Stockholder Equity
Common Stock584,000
Retained Earnings 6,578,000
Accumulated Other Comprehensive Income 136,000
Other Stockholders Equity 1,677,000
Total Stockholder Equity (as reported)8,975,000
Total Stockholder Equity (calculated)8,975,000
+/-0
Other
Capital Stock584,000
Cash and Short Term Investments 1,056,000
Common Stock Shares Outstanding 195,190
Current Deferred Revenue204,000
Liabilities and Stockholders Equity 15,539,000
Net Debt 2,177,000
Net Invested Capital 11,852,000
Net Working Capital 828,000
Property Plant and Equipment Gross 2,983,000
Short Long Term Debt Total 3,038,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-31
> Total Assets 
2,620,935
3,090,935
5,373,540
4,717,000
10,498,000
9,555,000
9,524,000
9,120,000
8,969,000
9,178,000
9,360,000
9,907,000
10,148,000
10,956,000
10,212,000
9,917,000
10,514,000
11,081,000
13,319,000
14,210,000
15,868,000
15,539,000
15,539,00015,868,00014,210,00013,319,00011,081,00010,514,0009,917,00010,212,00010,956,00010,148,0009,907,0009,360,0009,178,0008,969,0009,120,0009,524,0009,555,00010,498,0004,717,0005,373,5403,090,9352,620,935
   > Total Current Assets 
1,731,644
1,789,831
1,911,978
1,303,000
2,355,000
1,655,000
1,837,000
1,794,000
1,731,000
1,706,000
1,822,000
2,421,000
2,501,000
2,838,000
2,331,000
2,677,000
2,950,000
3,295,000
3,582,000
3,710,000
3,304,000
3,444,000
3,444,0003,304,0003,710,0003,582,0003,295,0002,950,0002,677,0002,331,0002,838,0002,501,0002,421,0001,822,0001,706,0001,731,0001,794,0001,837,0001,655,0002,355,0001,303,0001,911,9781,789,8311,731,644
       Cash And Cash Equivalents 
482,376
449,199
148,369
424,000
974,000
479,000
463,000
486,000
494,000
267,000
318,000
740,000
507,000
1,285,000
761,000
1,049,000
1,262,000
1,288,000
1,336,000
1,263,000
899,000
861,000
861,000899,0001,263,0001,336,0001,288,0001,262,0001,049,000761,0001,285,000507,000740,000318,000267,000494,000486,000463,000479,000974,000424,000148,369449,199482,376
       Short-term Investments 
0
0
0
0
0
96,000
0
53,000
61,000
38,000
8,000
24,000
20,000
19,000
38,000
63,000
94,000
139,000
186,000
212,000
243,000
195,000
195,000243,000212,000186,000139,00094,00063,00038,00019,00020,00024,0008,00038,00061,00053,000096,00000000
       Net Receivables 
438,545
903,218
847,109
567,000
891,000
0
870,000
0
0
0
0
919,000
675,000
804,000
820,000
738,000
821,000
880,000
939,000
1,134,000
1,256,000
1,140,000
1,140,0001,256,0001,134,000939,000880,000821,000738,000820,000804,000675,000919,0000000870,0000891,000567,000847,109903,218438,545
       Inventory 
773,436
403,946
377,058
261,000
432,000
307,000
363,000
405,000
434,000
537,000
616,000
627,000
547,000
566,000
578,000
597,000
647,000
780,000
854,000
878,000
907,000
1,031,000
1,031,000907,000878,000854,000780,000647,000597,000578,000566,000547,000627,000616,000537,000434,000405,000363,000307,000432,000261,000377,058403,946773,436
       Other Current Assets 
37,287
33,468
539,442
51,000
58,000
773,000
141,000
850,000
742,000
864,000
880,000
1,030,000
1,427,000
968,000
954,000
968,000
947,000
317,000
423,000
325,000
-1,000
304,000
304,000-1,000325,000423,000317,000947,000968,000954,000968,0001,427,0001,030,000880,000864,000742,000850,000141,000773,00058,00051,000539,44233,46837,287
   > Long-term Assets 
889,291
1,301,104
3,461,562
3,414,000
8,143,000
7,900,000
7,687,000
7,326,000
7,238,000
7,472,000
7,538,000
7,486,000
7,647,000
8,118,000
7,881,000
7,240,000
7,564,000
7,785,000
9,737,000
10,500,000
12,564,000
12,095,000
12,095,00012,564,00010,500,0009,737,0007,785,0007,564,0007,240,0007,881,0008,118,0007,647,0007,486,0007,538,0007,472,0007,238,0007,326,0007,687,0007,900,0008,143,0003,414,0003,461,5621,301,104889,291
       Property Plant Equipment 
0
726,458
699,906
500,000
666,000
758,000
623,000
534,000
505,000
500,000
602,000
722,000
686,000
651,000
678,000
673,000
805,000
840,000
1,035,000
1,275,000
1,434,000
1,595,000
1,595,0001,434,0001,275,0001,035,000840,000805,000673,000678,000651,000686,000722,000602,000500,000505,000534,000623,000758,000666,000500,000699,906726,4580
       Goodwill 
0
0
0
1,663,000
4,346,000
4,403,000
4,579,000
4,552,000
4,718,000
4,799,000
4,823,000
4,694,000
4,882,000
5,164,000
5,178,000
4,838,000
4,970,000
5,059,000
4,964,000
5,173,000
5,340,000
5,254,000
5,254,0005,340,0005,173,0004,964,0005,059,0004,970,0004,838,0005,178,0005,164,0004,882,0004,694,0004,823,0004,799,0004,718,0004,552,0004,579,0004,403,0004,346,0001,663,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
79,000
92,000
113,000
103,000
166,000
127,000
140,000
0
0
0
0
0000140,000127,000166,000103,000113,00092,00079,00000000000000
       Intangible Assets 
254,829
462,960
595,071
721,000
2,537,000
2,293,000
2,169,000
1,953,000
1,641,000
1,525,000
1,483,000
1,462,000
1,219,000
1,055,000
875,000
817,000
870,000
839,000
2,973,000
3,159,000
4,816,000
4,232,000
4,232,0004,816,0003,159,0002,973,000839,000870,000817,000875,0001,055,0001,219,0001,462,0001,483,0001,525,0001,641,0001,953,0002,169,0002,293,0002,537,000721,000595,071462,960254,829
       Long-term Assets Other 
634,462
111,686
2,166,585
354,000
484,000
106,000
155,000
65,000
79,000
63,000
48,000
55,000
106,000
282,000
132,000
139,000
164,000
200,000
236,000
261,000
311,000
267,000
267,000311,000261,000236,000200,000164,000139,000132,000282,000106,00055,00048,00063,00079,00065,000155,000106,000484,000354,0002,166,585111,686634,462
> Total Liabilities 
1,055,655
1,307,166
3,408,586
2,308,000
5,720,000
5,291,000
5,507,000
4,703,000
4,377,000
4,355,000
4,767,000
5,305,000
5,306,000
5,410,000
4,735,000
4,181,000
4,259,000
4,072,000
6,047,000
5,824,000
6,804,000
6,564,000
6,564,0006,804,0005,824,0006,047,0004,072,0004,259,0004,181,0004,735,0005,410,0005,306,0005,305,0004,767,0004,355,0004,377,0004,703,0005,507,0005,291,0005,720,0002,308,0003,408,5861,307,1661,055,655
   > Total Current Liabilities 
854,097
744,129
2,791,317
707,000
1,521,000
1,886,000
2,554,000
2,062,000
1,853,000
1,612,000
1,808,000
2,336,000
2,336,000
3,061,000
2,418,000
1,949,000
2,238,000
2,394,000
2,814,000
2,824,000
3,112,000
2,616,000
2,616,0003,112,0002,824,0002,814,0002,394,0002,238,0001,949,0002,418,0003,061,0002,336,0002,336,0001,808,0001,612,0001,853,0002,062,0002,554,0001,886,0001,521,000707,0002,791,317744,129854,097
       Short-term Debt 
0
98,354
1,970,716
31,000
65,000
514,000
917,000
566,000
308,000
45,000
197,000
723,000
373,000
623,000
27,000
39,000
149,000
306,000
431,000
55,000
262,000
42,000
42,000262,00055,000431,000306,000149,00039,00027,000623,000373,000723,000197,00045,000308,000566,000917,000514,00065,00031,0001,970,71698,3540
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
2,750,000
194,000
707,000
25,000
37,000
111,000
268,000
396,000
17,000
222,000
-1,000
-1,000222,00017,000396,000268,000111,00037,00025,000707,000194,0002,750,00000000000000
       Accounts payable 
0
305,345
397,544
525,000
1,142,000
1,108,000
1,159,000
1,036,000
1,172,000
1,294,000
261,000
247,000
312,000
342,000
274,000
281,000
364,000
403,000
513,000
596,000
573,000
537,000
537,000573,000596,000513,000403,000364,000281,000274,000342,000312,000247,000261,0001,294,0001,172,0001,036,0001,159,0001,108,0001,142,000525,000397,544305,3450
       Other Current Liabilities 
854,097
75,965
79,107
52,000
70,000
110,000
129,000
63,000
79,000
116,000
1,239,000
1,196,000
-1,000
1,466,000
1,713,000
1,460,000
1,549,000
1,547,000
1,662,000
1,850,000
2,026,000
1,833,000
1,833,0002,026,0001,850,0001,662,0001,547,0001,549,0001,460,0001,713,0001,466,000-1,0001,196,0001,239,000116,00079,00063,000129,000110,00070,00052,00079,10775,965854,097
   > Long-term Liabilities 
201,558
563,037
617,269
1,601,000
4,199,000
3,405,000
2,953,000
2,641,000
2,524,000
2,743,000
2,959,000
2,969,000
2,970,000
2,349,000
2,317,000
2,232,000
2,021,000
1,678,000
3,233,000
3,000,000
3,692,000
3,948,000
3,948,0003,692,0003,000,0003,233,0001,678,0002,021,0002,232,0002,317,0002,349,0002,970,0002,969,0002,959,0002,743,0002,524,0002,641,0002,953,0003,405,0004,199,0001,601,000617,269563,037201,558
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
1,065,000
906,000
692,000
721,000
698,000
757,000
703,000
917,000
932,000
1,054,000
0
01,054,000932,000917,000703,000757,000698,000721,000692,000906,0001,065,00000000000000
> Total Stockholder Equity
1,545,030
1,783,769
1,954,466
2,409,000
4,574,000
4,263,000
4,013,000
4,415,000
4,590,000
4,821,000
4,594,000
4,603,000
5,002,000
5,672,000
5,584,000
5,813,000
6,310,000
7,039,000
7,271,000
8,386,000
9,064,000
8,975,000
8,975,0009,064,0008,386,0007,271,0007,039,0006,310,0005,813,0005,584,0005,672,0005,002,0004,603,0004,594,0004,821,0004,590,0004,415,0004,013,0004,263,0004,574,0002,409,0001,954,4661,783,7691,545,030
   Common Stock
437,799
437,799
437,799
438,000
2,148,000
2,151,000
2,151,000
2,151,000
0
2,151,000
2,151,000
2,154,000
2,614,000
2,614,000
2,614,000
2,614,000
2,614,000
2,614,000
2,614,000
584,000
584,000
584,000
584,000584,000584,0002,614,0002,614,0002,614,0002,614,0002,614,0002,614,0002,614,0002,154,0002,151,0002,151,00002,151,0002,151,0002,151,0002,148,000438,000437,799437,799437,799
   Retained Earnings Total Equity0000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-162,000
-413,000
-127,000
368,000
136,000
136,000368,000-127,000-413,000-162,00000000000000000000
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 
1,107,231
1,345,970
1,516,667
-169,000
39,000
-281,000
-414,000
-366,000
4,590,000
56,000
-226,000
-211,000
-127,000
143,000
-293,000
-612,000
-698,000
-539,000
-806,000
1,508,000
1,667,000
1,677,000
1,677,0001,667,0001,508,000-806,000-539,000-698,000-612,000-293,000143,000-127,000-211,000-226,00056,0004,590,000-366,000-414,000-281,00039,000-169,0001,516,6671,345,9701,107,231



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,252,000
Cost of Revenue-1,707,000
Gross Profit3,545,0003,545,000
 
Operating Income (+$)
Gross Profit3,545,000
Operating Expense-2,923,000
Operating Income604,000622,000
 
Operating Expense (+$)
Research Development1,630,000
Selling General Administrative230,000
Selling And Marketing Expenses1,594,000
Operating Expense2,923,0003,454,000
 
Net Interest Income (+$)
Interest Income27,000
Interest Expense-144,000
Other Finance Cost-12,000
Net Interest Income-129,000
 
Pretax Income (+$)
Operating Income604,000
Net Interest Income-129,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)441,000767,000
EBIT - interestExpense = 439,000
441,000
487,000
Interest Expense144,000
Earnings Before Interest and Taxes (EBIT)583,000585,000
Earnings Before Interest and Taxes (EBITDA)1,274,000
 
After tax Income (+$)
Income Before Tax441,000
Tax Provision-98,000
Net Income From Continuing Ops343,000343,000
Net Income343,000
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses4,630,000
Total Other Income/Expenses Net-163,000129,000
 

Technical Analysis of Ucb
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ucb. The general trend of Ucb is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ucb's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of UCB SA ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 60.44 > 60.21 > 56.77.

Tweet this
UCB SA ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of UCB SA ADR. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

UCB SA ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of UCB SA ADR. The current macd is 2.34549197.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ucb price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ucb. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ucb price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
UCB SA ADR Daily Moving Average Convergence/Divergence (MACD) ChartUCB SA ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of UCB SA ADR. The current adx is 41.47.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ucb shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
UCB SA ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of UCB SA ADR. The current sar is 57.97.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
UCB SA ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of UCB SA ADR. The current rsi is 70.62. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
UCB SA ADR Daily Relative Strength Index (RSI) ChartUCB SA ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of UCB SA ADR. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ucb price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
UCB SA ADR Daily Stochastic Oscillator ChartUCB SA ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of UCB SA ADR. The current cci is 103.77.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
UCB SA ADR Daily Commodity Channel Index (CCI) ChartUCB SA ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of UCB SA ADR. The current cmo is 38.96.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
UCB SA ADR Daily Chande Momentum Oscillator (CMO) ChartUCB SA ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of UCB SA ADR. The current willr is -15.88541667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
UCB SA ADR Daily Williams %R ChartUCB SA ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of UCB SA ADR.

UCB SA ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of UCB SA ADR. The current atr is 0.93104367.

UCB SA ADR Daily Average True Range (ATR) ChartUCB SA ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of UCB SA ADR. The current obv is 260,635.

UCB SA ADR Daily On-Balance Volume (OBV) ChartUCB SA ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of UCB SA ADR. The current mfi is 52.38.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
UCB SA ADR Daily Money Flow Index (MFI) ChartUCB SA ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for UCB SA ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-24BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-30CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

UCB SA ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of UCB SA ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.619
Ma 20Greater thanMa 5059.619
Ma 50Greater thanMa 10053.346
Ma 100Greater thanMa 20046.872
OpenGreater thanClose61.262
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ucb with someone you think should read this too:
  • Are you bullish or bearish on Ucb? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ucb? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about UCB SA ADR

I send you an email if I find something interesting about UCB SA ADR.


Comments

How you think about this?

Leave a comment

Stay informed about UCB SA ADR.

Receive notifications about UCB SA ADR in your mailbox!